Investor
Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 435 (TSX: $RIV.TO)
(TSXV: $RTI.V) (TSXV: $XLY.V) (NASDAQ: $NEPT) (TSX: $NEPT.TO), (NYSE: $ACB)
(TSX: $ACB.TO)
Delta, Kelowna, BC, June 30, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/06301RIV-RTI-XLY-NEPT-ACB.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Dynaleo, the Edmonton, AB
manufacturer of premium cannabis-infused gummies, has signed a letter of intent with its first
international partner.
Dynaleo, part of Canopy Rivers' (TSX:RIV) (OTC:CNPOF) portfolio of disruptive cannabis
companies, made the announcement a week after they received their Standard
Processing License from Health Canada.
"We are pleased to have entered
into a non-binding Letter of Intent with Pantry, a premium cannabis-infused
food brand. This agreement complements our already existing relationships with
cannabis brands in Canada," says Michael Krestell, Executive Chairman.
"Pantry's focus on quality
products made with natural ingredients fits perfectly with our own commitment
to manufacturing gummies that are of the highest quality," he adds.
Based in Los Angeles, California,
Pantry was created by a group of award-winning chefs and offers a variety of
cannabis-infused food products. This is the brand's first foray into Canada.
According to the agreement, Dynaleo
will manufacture and distribute cannabis-infused vegan gummies under the Pantry
brand within the Canadian market.
"Pantry is excited to combine
our passion for creating delicious health conscious cannabis products with
Dynaleo's operational excellence. Dynaleo's facility and their state-of-the-art
equipment will help us achieve best-in-class efficiencies in the market. More
importantly, the Dynaleo team is what really inspired us. We are a people and
culture driven organization and we couldn't be more impressed with Michael
Krestell, Tom Vella and the whole Dynaleo team", says Scott Jennings, CEO
and Co-Founder of Pantry.
Production on the Pantry-branded
vegan gummies is expected to begin in later this year at Dynaleo's state of the
art, 27,000 square-foot facility, the first industrial-scale and purpose-built
high-volume cannabis edible factory in Canada.
"Dynaleo is committed to
providing innovative gummy solutions for our partners. We are uniquely
positioned, because of the proprietary nature of our high-volume factory, to
meet consumer demand for gummies in Canada," says Krestell.
Solid edible products, led by
gummies, currently comprise more than 90% of the top-selling infused products.
Deloitte estimates that Canada's edibles market is worth $1.6 billion annually,
while Arcview Market Research and BDS Analytics predict that the North American
edibles market will be worth more than $4.1 billion by 2022. A new report from
the market research firm Headset also shows an uptick in gummy purchases in
several jurisdictions since the beginning of the COVID-19 pandemic.
Radient
Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF), a manufacturer of high quality
cannabinoid-based formulations and products, has received a Health Canada license amendment
for the sale of cannabis extracts, cannabis edibles and cannabis topicals. This license, which allows for the sale of
all three categories of extracted products, is a significant milestone in
commercializing the Company’s product offerings and launching its 2.0 product
portfolio. Radient is also pleased to
announce that it has entered into a manufacturing and service agreement with
Premium 5 Ltd. (“P5”) for multiple products under its brand of premium
concentrates.
“Receiving this license amendment is
a critical step in diversifying and evolving Radient’s business model through
new products and customers,” said Denis Taschuk, Chief Executive Officer, Radient
Technologies. “The sales license will give Radient the ability to leverage our
unique formulations for exciting new consumer products.”
In anticipation of receiving its
sales license, Radient has started the process of increasing its product
manufacturing and filling capabilities.
The Company will have substantial capacity for white label production of
unique 2.0 products that uses its extensive formulation library. Radient believes this will be a significant
advantage in signing further manufacturing agreements and capturing new revenue
opportunities. Over the coming month,
Radient looks forward to updating stakeholders and customers on innovative
offerings.
The partnership with P5, Canada’s
preeminent concentrate supplier, will involve multiple new product lines,
bringing P5 concentrates to market with final manufacturing completed by
Radient. Under the renewable one-year
agreement, Radient will supply distillate, and provide manufacturing services
for a minimum of 240,000 units. The
first products planned will be a live resin vape cartridge, along with a live
resin X cartridge that will be blended with Radient’s THC distillate.
Premium 5 is Canada’s leader in
bringing quality concentrate products and curated devices to market. P5
launched the first live resin concentrates in the country and has quickly
become synonymous with the highest levels of quality and cutting-edge products.
Auxly
Cannabis Group Inc. (TSXV: XLY)
, a consumer packaged goods company in the cannabis products market, announced that its wholly owned subsidiary,
Dosecann LD Inc. has received its Cannabis Research Licence from Health Canada
pursuant to the Cannabis Act. This
licence permits Dosecann to administer cannabis extracts, edible cannabis and
cannabis topicals to human subjects for purposes of palatability and sensory
testing at its state-of-the-art facility located in Charlottetown, Prince
Edward Island.
Dosecann has spent the last few
years developing highly accurate, proprietary processes in order to create the
Company’s first-class suite of cannabis products, however, due to regulatory
restrictions, the product development team was unable to fully evaluate the
impact of cannabis infusion on the taste of its edible products. With this
licence, Dosecann can now conduct broader in-house testing, incorporating
consumer input and feedback on attributes such as flavour, aroma, texture or
mouthfeel, to better evaluate later-stage product formulations.
“Up until now, our team of product developers
at Dosecann knew we had great tasting non-infused formulations, but we were
unable to assess the impact of the addition of cannabis extracts. For food
product developers, it is critical that we have the ability to quickly evaluate
different product attributes; a tool that wasn’t available to us until now,”
said Peter Crooks, Chief Product Innovation Officer, Dosecann. “We will very
quickly begin to apply the ability, under this research licence, to conduct
organoleptic assessments in order to evaluate the impact of different cannabis
extracts on our edible formulations. Having this ability to conduct in-house
testing will lead to better tasting products for our consumers, generate
additional proprietary knowledge into our approach to flavour development,
processing and manufacturing, and support the optimization of the cannabis
extracts used in our different edible product segments.”
Hugo Alves, CEO of Auxly added:
“This is a key license for Auxly’s product innovation strategy and our efforts
to develop incredible cannabis products that deliver on a consumer promise of
quality, safety and efficacy. The incorporation of consumer input and feedback
during product development is critical to those efforts and has been
demonstrated repeatedly to reduce costs and time to market and increase product
acceptance by consumers. Peter and his team at Dosecann now have all of the
tools they need to innovate and delight consumers with new and exciting
cannabis products, all accurately dosed and manufactured to Dosecann’s exacting
standards.”
Neptune
Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated
health and wellness company, announced that it has been authorized by
Health Canada to sell cannabis products to provinces and territories. This
sales license includes edibles, vapes, extracts, and topicals, including
beverage products to name a few. This authorization adds to previously held
processing license and will expand Neptune's cannabis operations to include
proprietary branded products. Additionally, the authorization enhances the
capabilities of the Company's white label offerings, providing incremental
value and service offerings to its B2B customers.
In addition to the sales license,
Neptune's cold storage and added operating space have been approved for
operation. The enlarged cold storage and approved space in the Sherbooke
facility provide greater capacity to process larger volumes of product and
store at low temperature to protect product. The increased storage adds
significantly to Neptune's logistic capabilities and provides incremental
solutions to the Company's clients.
"The receipt of our sales
license is a major milestone for Neptune and significantly expands our cannabis
revenue opportunities. We are already advanced in our development of our own
brands, and look forward to announcing new branded products. We also see
potential for future co-branded opportunities. Additionally, the license
enhances our white label business, allowing us to ship direct to provincial
customers on behalf of our partners. We plan to further enhance our production
capabilities to expand both our branded and white label product solutions and
product forms and capture incremental value within the growing Canadian
cannabis market," said Michael Cammarata, Chief Executive Officer of
Neptune Wellness Solutions. "The
sales license, along with our approval to begin operating our expanded space
and cold storage significantly increase our capabilities to support our
customers, solve the storage limitation inherent among many current and
potential cannabis customers and provide significantly higher value to our
partners and customers, capturing incremental revenue and growth."
Aurora
Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the
future of cannabinoids worldwide, announced yesterday that Co-Founder Terry
Booth has retired from his role as Director of the Company, effective June 26,
2020. Mr. Booth was the Chief Executive Officer of Aurora from December 2014
through February 2020 and served on Aurora's Board of Directors since December
2014.
"On behalf of our Board of
Directors and management team, I would like to thank Terry for his leadership
over the years and for his tenure as a director," said Michael Singer,
Executive Chairman and Interim CEO of Aurora. "As one of the original cannabis
visionaries, Terry leaves an enviable legacy in the form of Aurora Cannabis. He
helped set the table for the Company to lead in Canada and globally, and we
continue to execute our plan to do so profitably."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
